The Latest Breaking News from Biogen Inc

3 of the Best Stocks in 1 of Wall Street's Worst-Rated Industry

After years of robust growth, the biotech industry has struggled since last year due to several headwinds, including regulatory concerns, inflation, and the Fed’s aggressive rate hikes, which have sucked out speculative capital. Despite currently being one of the poorly-rated industries, investors could consider buying top-biotech stocks Gilead (GILD), Vertex…

StockNews.com · Mar 29, 2023

4 Biotech Stocks You Don’t Want to Miss out on in 2023

The biotech industry is growing with considerable developments and government initiatives. Given the solid prospects of the industry, fundamentally sound biotech stocks Vertex Pharmaceuticals (VRTX), Biogen (BIIB), Exelixis (EXEL), and Cidara Therapeutics (CDTX) could be excellent buys. Keep reading.

StockNews.com · Mar 24, 2023

The VA will pay for some to get new Alzheimer’s drug

The U.S. Veterans Health Administration will pay for some beneficiaries to get a new Alzheimer’s disease drug from Eisai Co. and Biogen Inc., positive news for a treatment that Eisai expects to bring in billions of dollar in sales in the next few years.

Tribune News Service · Mar 13, 2023

3 Stocks to Get Bullish on Now

The Fed’s recent 25 bps rate hike in response to cooling inflation and Powell’s dovish comments improved investor sentiment. Amid growing optimism over the slowing interest rate hikes, we think fundamentally strong stocks Archer-Daniels-Midland (ADM), Biogen (BIIB), and MasterCraft (MCFT) are ideal additions to one’s portfolio. Read on….

StockNews.com · Feb 6, 2023

3 Biotech Stocks to Get in on Before It’s Too Late

Rapidly growing market for personalized medicines and revolutionary technologies like 3D bioprinting is expected to bolster the biotech industry. Moreover, rising government initiatives should support its growth. Hence, quality biotech stocks Vertex Pharmaceuticals (VRTX), Biogen (BIIB), and Jazz Pharmaceuticals (JAZZ) might be ideal buys. Continue reading.

StockNews.com · Feb 1, 2023

3 Top-Rated Stocks to Buy for the Long Haul

Amid economic turmoil and recessionary fears, market volatility is anticipated to continue. However, this could be an opportune time for investors to scoop up quality top-rated stocks Gilead Sciences (GILD), Biogen (BIIB), and AudioCodes (AUDC) for the long haul. Read on….

StockNews.com · Jan 24, 2023

Sitting on Cash? These 3 Stocks Are Great Buys Right Now

The U.S. economy is gripped by fears of an economic slowdown due to several macroeconomic and geopolitical headwinds. However, the uncertain market conditions have created opportunities for investors sitting on cash to buy quality stocks at attractive prices. Biogen (BIIB), AutoNation (AN), and AdvanSix (ASIX), which are trading at discounts…

StockNews.com · Jan 20, 2023

3 Nasdaq Stocks You'll Regret Not Buying This Year

Although macroeconomic headwinds kept the stock market under immense pressure last year, the declining inflation rates have increased investor optimism recently. Hence, quality Nasdaq stocks Comcast Corporation (CMCSA), Honeywell International (HON), and Biogen (BIIB) might be solid buys this year. Read on….

StockNews.com · Jan 17, 2023

3 Biotech Stocks to Help Boost Your Portfolio in January

Increased government initiatives and the rising adoption of biotechnology in healthcare and agriculture are likely to enhance the growth of the biotech industry. Hence, fundamentally sound biotech stocks Vertex Pharmaceuticals (VRTX), Biogen (BIIB), and Jazz Pharmaceuticals (JAZZ) might be ideal additions to your portfolio as they look well-positioned to capitalize…

StockNews.com · Jan 12, 2023

3 Value Stocks Worth Your Attention in 2023

With the Fed slated to increase rates aggressively this year to curb inflation, value stocks could shine again. Thus, investors could invest in shares of fundamentally strong stocks Biogen (BIIB), Dow Inc. (DOW), and Albertsons Companies (ACI) that are trading at attractive valuations. Continue reading….

StockNews.com · Jan 6, 2023